Michael Farber

Davis Polk advised the underwriters in connection with an initial public offering of 11,000,000 shares of common stock of Nurix Therapeutics, Inc. at $19 per share, for total gross proceeds…

Davis Polk advised Toyota Motor Credit Corporation in connection with an SEC-registered offering of $750 million aggregate principal amount of 0.450% diversity and inclusion medium-term…

Davis Polk advised Raízen Fuels Finance S.A., as issuer and Raízen Combustiveis S.A. and Raízen Energia S.A., as guarantors, in connection with Raízen Fuels’ $225 million reopening of its 5…

Davis Polk advised the representatives of the several underwriters in connection with the $296 million SEC-registered offering of 9,545,000 shares of common stock of 1Life Healthcare,…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Intuit Inc. of $500 million aggregate principal amount of 0.650% notes due 2023, …

Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Schlumberger Investment SA of $900 million aggregate principal amount of 2.650% senior notes due…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Xylem Inc. of $500 million aggregate principal amount of its 1.950% senior notes due…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Livent Corporation of $225 million aggregate principal amount of its 4.125%…

Davis Polk advised the representatives of the underwriters, in connection with the offering of $4.5 billion aggregate principal amount of notes issued by Merck & Co., Inc. The…

Davis Polk advised the sole book-running manager in an SEC-registered offering by Amerant Bancorp Inc. of $60 million aggregate principal amount of 5.750% notes due 2025. The notes are…